Your browser doesn't support javascript.
loading
Tau Exon 10 Inclusion by PrPC through Downregulating GSK3ß Activity.
Lidón, Laia; Llaó-Hierro, Laura; Nuvolone, Mario; Aguzzi, Adriano; Ávila, Jesús; Ferrer, Isidro; Del Río, José Antonio; Gavín, Rosalina.
Afiliação
  • Lidón L; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Scientific Park of Barcelona, The Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain.
  • Llaó-Hierro L; Department of Cell Biology, Physiology and Immunology, University of Barcelona, 08028 Barcelona, Spain.
  • Nuvolone M; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, 28031 Madrid, Spain.
  • Aguzzi A; Institute of Neuroscience, University of Barcelona, 08035 Barcelona, Spain.
  • Ávila J; Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Scientific Park of Barcelona, The Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain.
  • Ferrer I; Department of Cell Biology, Physiology and Immunology, University of Barcelona, 08028 Barcelona, Spain.
  • Del Río JA; Network Centre of Biomedical Research of Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Ministry of Economy and Competitiveness, 28031 Madrid, Spain.
  • Gavín R; Institute of Neuroscience, University of Barcelona, 08035 Barcelona, Spain.
Int J Mol Sci ; 22(10)2021 May 20.
Article em En | MEDLINE | ID: mdl-34065232
Tau protein is largely responsible for tauopathies, including Alzheimer's disease (AD), where it accumulates in the brain as insoluble aggregates. Tau mRNA is regulated by alternative splicing, and inclusion or exclusion of exon 10 gives rise to the 3R and 4R isoforms respectively, whose balance is physiologically regulated. In this sense, one of the several factors that regulate alternative splicing of tau is GSK3ß, whose activity is inhibited by the cellular prion protein (PrPC), which has different physiological functions in neuroprotection and neuronal differentiation. Moreover, a relationship between PrPC and tau expression levels has been reported during AD evolution. For this reason, in this study we aimed to analyze the role of PrPC and the implication of GSK3ß in the regulation of tau exon 10 alternative splicing. We used AD human samples and mouse models of PrPC ablation and tau overexpression. In addition, we used primary neuronal cultures to develop functional studies. Our results revealed a paralleled association between PrPC expression and tau 4R isoforms in all models analyzed. In this sense, reduction or ablation of PrPC levels induces an increase in tau 3R/4R balance. More relevantly, our data points to GSK3ß activity downstream from PrPC in this phenomenon. Our results indicate that PrPC plays a role in tau exon 10 inclusion through the inhibitory capacity of GSK3ß.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Príons / Regulação para Baixo / Éxons / Proteínas tau / Glicogênio Sintase Quinase 3 beta Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Príons / Regulação para Baixo / Éxons / Proteínas tau / Glicogênio Sintase Quinase 3 beta Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha